|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Deferred offering costs | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| Investments held in Trust Account | ||||||||
| Total Assets | ||||||||
| LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT | ||||||||
| Current liabilities | ||||||||
| Advance from related party | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Promissory note - related party | ||||||||
| Income taxes payable | ||||||||
| Total Current Liabilities | ||||||||
| Convertible note – related party | ||||||||
| Warrant liability | ||||||||
| Deferred underwriting fee payable | ||||||||
| Total Liabilities | ||||||||
| Class A common stock subject to possible redemption 31,625,000 shares at approximately $10.15 per share as of June 30, 2022 and December 31, 2021 | ||||||||
| Class A Common Stock | ||||||||
| Total class A common stock subject to possible redemption 31,625,000 shares at approximately $10.15 per share as of June 30, 2022 and December 31, 2021 | ||||||||
| STOCKHOLDERS' DEFICIT | ||||||||
| Common stock | ||||||||
| Class A Common Stock | ||||||||
| Class B Common Stock | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Class A Common Stock | ||||||||
| Class B Common Stock | ||||||||
| TOTAL STOCKHOLDERS' DEFICIT | ||||||||
| TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT |
Loading...
